サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1105593

全身性エリテマトーデスの世界市場規模調査：治療タイプ別（非ステロイド性抗炎症薬、抗マラリア薬、コルチコステロイド、生物製剤、その他）、投与経路別、地域別予測（2022年～2028年）

Global Systemic Lupus Erythematosus Market Size study, by Treatment Type (Non-Steroidal Anti-Inflammatory Drugs, Antimalarials, Corticosteroids, Biologics, and Others), Route of Administration, and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
全身性エリテマトーデスの世界市場規模調査：治療タイプ別（非ステロイド性抗炎症薬、抗マラリア薬、コルチコステロイド、生物製剤、その他）、投与経路別、地域別予測（2022年～2028年）
出版日: 2022年07月04日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の全身性エリテマトーデスの市場規模は、予測期間（2022年～2028年）中に7.1％以上のCAGRで成長すると予測されています。

バイオ製薬企業による全身性エリテマトーデスの医学的進歩と全身性エリテマトーデスの有病率の上昇は、全身性エリテマトーデス市場の成長を促進しています。しかし、高い治療費が市場の成長を抑制しています。

当レポートでは、世界の全身性エリテマトーデス市場について調査分析し、市場力学、業界分析、市場分析、競合情報など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の全身性エリテマトーデス市場の定義と範囲

第3章 世界の全身性エリテマトーデス市場力学

  • 全身性エリテマトーデス市場への影響分析（2020年～2028年）

第4章 世界の全身性エリテマトーデス市場業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 最高の投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-COVID-19以後の市場シナリオ

第6章 世界の全身性エリテマトーデス市場：治療タイプ別

  • 市場スナップショット
  • 世界の全身性エリテマトーデス市場実績－潜在分析：治療タイプ別
  • 世界の全身性エリテマトーデス市場の推定と予測（100万米ドル）（2018年～2028年）：治療タイプ別
  • 全身性エリテマトーデス市場、サブセグメント分析
    • 非ステロイド性抗炎症薬（NSAIDS）
    • 抗マラリア薬
    • コルチコステロイド
    • 生物製剤
    • その他

第7章 世界の全身性エリテマトーデス市場：投与経路別

  • 市場スナップショット
  • 世界の全身性エリテマトーデス市場実績－潜在分析：投与経路別
  • 世界の全身性エリテマトーデス市場の推定と予測（100万米ドル）（2018年～2028年）：投与経路別
  • 全身性エリテマトーデス市場、サブセグメント分析
    • 経口
    • 静脈
    • その他

第8章 世界の全身性エリテマトーデス市場、地域分析

  • 地域の市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Eli Lilly & Company
    • GlaxoSmithKline
    • Bristl Myers Squibb Company
    • F. Hoffmann-La Roche AG
    • Pfizer Limited
    • Novartis AG
    • Sanofi SA
    • ImmuPharma PLC
    • AstraZeneca
    • Viatris Inc

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Systemic Lupus Erythematosus Market, report scope
  • TABLE 2. Global Systemic Lupus Erythematosus Market estimates & forecasts by region 2018-2028 (USD Million)
  • TABLE 3. Global Systemic Lupus Erythematosus Market estimates & forecasts by Treatment Type 2018-2028 (USD Million)
  • TABLE 4. Global Systemic Lupus Erythematosus Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
  • TABLE 5. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 6. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. U.S. Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 17. U.S. Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. Canada Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 19. Canada Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. UK Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 22. UK Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. Germany Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 25. Germany Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. RoE Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 28. RoE Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. China Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 31. China Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. India Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 34. India Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. Japan Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 37. Japan Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. RoAPAC Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. Brazil Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 43. Brazil Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Mexico Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 46. Mexico Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. RoLA Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 49. RoLA Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. Row Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 52. Row Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. List of secondary sources, used in the study of global Systemic Lupus Erythematosus Market
  • TABLE 55. List of primary sources, used in the study of global Systemic Lupus Erythematosus Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Systemic Lupus Erythematosus Market, research methodology
  • FIG 2. Global Systemic Lupus Erythematosus Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Systemic Lupus Erythematosus Market, key trends 2021
  • FIG 5. Global Systemic Lupus Erythematosus Market, growth prospects 2022-2028
  • FIG 6. Global Systemic Lupus Erythematosus Market, porters 5 force model
  • FIG 7. Global Systemic Lupus Erythematosus Market, pest analysis
  • FIG 8. Global Systemic Lupus Erythematosus Market, value chain analysis
  • FIG 9. Global Systemic Lupus Erythematosus Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Systemic Lupus Erythematosus Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Systemic Lupus Erythematosus Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Systemic Lupus Erythematosus Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Systemic Lupus Erythematosus Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Systemic Lupus Erythematosus Market, regional snapshot 2018 & 2028
  • FIG 15. North America Systemic Lupus Erythematosus Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Systemic Lupus Erythematosus Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Systemic Lupus Erythematosus Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Systemic Lupus Erythematosus Market 2018 & 2028 (USD Million)
  • FIG 19. Global Systemic Lupus Erythematosus Market, company market share analysis (2021)
目次

Global Systemic Lupus Erythematosus Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.1% over the forecast period 2022-2028. An autoimmune disease is systemic lupus erythematosus (SLE). In this disorder, the immune system mistakenly destroys healthy tissue. Affected organs may include the kidneys, brain, skin, joints, and other tissues. SLE affects women around 10 times more frequently than it does males. At any age, anyone may be impacted. However, the majority of those afflicted are young women between the ages of 15 and 44. Chest discomfort, weariness, enlarged lymph nodes, and other symptoms are some of the warning signs and symptoms of this disorder. The main driver of the market is medical Advancements by Biopharmaceutical Companies in SLE and increasing Prevalence of Systemic Lupus Erythematosus. For instance, Belimumab is the first biological drug authorised for the treatment of Systemic Lupus Erythematosus (SLE), according to the research "Biologics in Systemic Lupus Erythematosus (SLE)" released in March 2022. (anti-BlyS). More recent studies demonstrate that supplementing the standard of care for lupus nephritis with belimumab increases the renal response rate. Other biological therapies targeting B cells (such as obinutuzumab, a newer generation anti-CD20), and the type I interferon pathway (such as anifrolumab), have also showed potential in randomized placebo-controlled clinical studies in SLE. Furthermore, The HealthWell Foundation, an independent non-profit that provides financial assistance to Americans without health insurance, announce that its fund for persons with Systemic Lupus Erythematosus has been reopened as of December 2020. (SLE). As a result, it is anticipated to stimulate market expansion overall throughout the anticipated period. However, high Cost of Treatment impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Systemic Lupus Erythematosus Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market share owing to increased awareness about the disease in the society and growing support towards biopharmaceutical manufacturers. However, APAC is fastest growing region due to changing lifestyle and growing population and increase in the adoption of advanced technologies in this region.

Major market players included in this report are:

GlaxoSmithKline

Bristl Myers Squibb Company

F. Hoffmann-La Roche AG

Pfizer Limited

Novartis AG

Sanofi SA

ImmuPharma PLC

AstraZeneca

Viatris Inc

Eli Lilly & Company

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

Antimalarials

Corticosteroids

Biologics

Others

By Route of Administration:

Oral

Intravenous

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Systemic Lupus Erythematosus Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Systemic Lupus Erythematosus Market, by region, 2020-2028 (USD Million)
    • 1.2.2. Systemic Lupus Erythematosus Market, by Treatment Type, 2020-2028 (USD Million)
    • 1.2.3. Systemic Lupus Erythematosus Market, by Route of Administration, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Systemic Lupus Erythematosus Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Systemic Lupus Erythematosus Market Dynamics

  • 3.1. Systemic Lupus Erythematosus Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Medical Advancements by Biopharmaceutical Companies in SLE
      • 3.1.1.2. Increasing Prevalence of Systemic Lupus Erythematosus
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Treatment
      • 3.1.2.2. Several Misconceptions and Social Stigmas
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rise in the research and development activities
      • 3.1.3.2. Launch of effective therapies

Chapter 4. Global Systemic Lupus Erythematosus Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Systemic Lupus Erythematosus Market, by Treatment Type

  • 6.1. Market Snapshot
  • 6.2. Global Systemic Lupus Erythematosus Market by Treatment Type, Performance - Potential Analysis
  • 6.3. Global Systemic Lupus Erythematosus Market Estimates & Forecasts by Treatment Type, 2018-2028 (USD Million)
  • 6.4. Systemic Lupus Erythematosus Market, Sub Segment Analysis
    • 6.4.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
    • 6.4.2. Antimalarials
    • 6.4.3. Corticosteroids
    • 6.4.4. Biologics
    • 6.4.5. Others

Chapter 7. Global Systemic Lupus Erythematosus Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Systemic Lupus Erythematosus Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Systemic Lupus Erythematosus Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Million)
  • 7.4. Systemic Lupus Erythematosus Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Intravenous
    • 7.4.3. Other

Chapter 8. Global Systemic Lupus Erythematosus Market, Regional Analysis

  • 8.1. Systemic Lupus Erythematosus Market, Regional Market Snapshot
  • 8.2. North America Systemic Lupus Erythematosus Market
    • 8.2.1. U.S. Systemic Lupus Erythematosus Market
      • 8.2.1.1. Treatment Type breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada Systemic Lupus Erythematosus Market
  • 8.3. Europe Systemic Lupus Erythematosus Market Snapshot
    • 8.3.1. U.K. Systemic Lupus Erythematosus Market
    • 8.3.2. Germany Systemic Lupus Erythematosus Market
    • 8.3.3. France Systemic Lupus Erythematosus Market
    • 8.3.4. Spain Systemic Lupus Erythematosus Market
    • 8.3.5. Italy Systemic Lupus Erythematosus Market
    • 8.3.6. Rest of Europe Systemic Lupus Erythematosus Market
  • 8.4. Asia-Pacific Systemic Lupus Erythematosus Market Snapshot
    • 8.4.1. China Systemic Lupus Erythematosus Market
    • 8.4.2. India Systemic Lupus Erythematosus Market
    • 8.4.3. Japan Systemic Lupus Erythematosus Market
    • 8.4.4. Australia Systemic Lupus Erythematosus Market
    • 8.4.5. South Korea Systemic Lupus Erythematosus Market
    • 8.4.6. Rest of Asia Pacific Systemic Lupus Erythematosus Market
  • 8.5. Latin America Systemic Lupus Erythematosus Market Snapshot
    • 8.5.1. Brazil Systemic Lupus Erythematosus Market
    • 8.5.2. Mexico Systemic Lupus Erythematosus Market
  • 8.6. Rest of The World Systemic Lupus Erythematosus Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Eli Lilly & Company
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. GlaxoSmithKline
    • 9.2.3. Bristl Myers Squibb Company
    • 9.2.4. F. Hoffmann-La Roche AG
    • 9.2.5. Pfizer Limited
    • 9.2.6. Novartis AG
    • 9.2.7. Sanofi SA
    • 9.2.8. ImmuPharma PLC
    • 9.2.9. AstraZeneca
    • 9.2.10. Viatris Inc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption